PANK4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.32070000000451E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.71820000000245E-06 |
Normal-vs-Stage2 |
1.72547999999217E-05 |
Normal-vs-Stage3 |
2.35489999999006E-05 |
Normal-vs-Stage4 |
4.90759999971502E-07 |
Stage1-vs-Stage2 |
2.461800E-01 |
Stage1-vs-Stage3 |
1.221240E-01 |
Stage1-vs-Stage4 |
1.116400E-02 |
Stage2-vs-Stage3 |
8.484000E-01 |
Stage2-vs-Stage4 |
3.076800E-01 |
Stage3-vs-Stage4 |
4.683000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.21610000003436E-06 |
Normal-vs-AfricanAmerican |
2.43929999999004E-06 |
Normal-vs-Asian |
1.762470E-04 |
Caucasian-vs-AfricanAmerican |
5.207800E-01 |
Caucasian-vs-Asian |
2.704800E-01 |
AfricanAmerican-vs-Asian |
3.310200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.76170000043952E-07 |
Normal-vs-Female |
3.67850000000391E-05 |
Male-vs-Female |
9.921600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.30959999999447E-05 |
Normal-vs-Extreme_Weight |
4.16480000000607E-05 |
Normal-vs-Obese |
2.28980000005485E-06 |
Normal-vs-Extreme_Obese |
1.459390E-01 |
Normal_Weight-vs-Extreme_Weight |
4.925200E-01 |
Normal_Weight-vs-Obese |
8.417000E-01 |
Normal_Weight-vs-Extreme_Obese |
4.618200E-01 |
Extreme_Weight-vs-Obese |
5.713600E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.268600E-01 |
Obese-vs-Extreme_Obese |
4.925400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.140300E-03 |
Normal-vs-Age(41-60Yrs) |
1.85428999999182E-05 |
Normal-vs-Age(61-80Yrs) |
7.30120000014267E-07 |
Normal-vs-Age(81-100Yrs) |
1.82198999999494E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.494800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.354600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.729630E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.730200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.066000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.542000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
4.765000E-04 |
Normal-VS-Type2 PRCC |
7.73899833106384E-11 |
Normal-VS-KIRP CIMP |
3.69890000000428E-05 |
Normal-VS-Unclassified PRCC |
3.587200E-04 |
Type1 PRCC-VS-Type2 PRCC |
4.78469999953823E-07 |
Type1 PRCC-VS-KIRP CIMP |
5.925600E-02 |
Type1 PRCC-VS-Unclassified PRCC |
2.865400E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.750800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.842400E-03 |
KIRP CIMP-VS-Unclassified PRCC |
1.714160E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.69140000005896E-07 |
Normal-vs-N1 |
1.36879999557138E-08 |
Normal-vs-N2 |
1.019660E-03 |
N0-vs-N1 |
1.957150E-01 |
N0-vs-N2 |
5.152000E-01 |
N1-vs-N2 |
9.667000E-01 |
|
|